[1] Connell PP, Weichselbaum RR. Gene therapy:the challenges of translating laboratory research into clinical practice[J]. J Clin Oncol, 2003, 21(12):2230-2231.
[2] Weichselbaum RR, Hallahan DE, Beckett MA, et al. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells[J]. Cancer nes, 1994, 54(16):4266-4269.
[3] Seethram S, Staba MJ, Schumm IP, et al. Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation[J]. Int J Oncol, 1999, 15(4):769-773.
[4] Gridley DS, Baer JR, Cao JD, et al. TNF-alpha gene and proton radiotherapy in an orthotopic brain tumor model[J]. Int J Oncol, 2002, 21(2):251-259.
[5] Sherman ML, Datta R, Hallahan DE. Ionizing radiation regulates expression of the c-jun protooncogene[J]. Natl Acad Sci USA, 1990, 87(15):5663-5670.
[6] Xian J, Yang H, Lin Y, et al. Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma[J]. Arch Otolaryngol Head Neck Surg, 2005, 131(12):1079-1085.
[7] Haupt S, Haupt Y. Importance of p53 for cancer onset and therapy[J]. Anti Cancer Drugs, 2006, 17(7):725-732.
[8] Mimeault M, Batra SK. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies[J]. Carcinogenesis, 2006, 27(1):1-22.
[9] Baker SJ, Markowitz S, Fearon ER, et al. Suppression of human colorectal carcinoma cell growth by wild-type p53[J]. Science, 1990, 249(4971):912-915.
[10] Guha A, Mukherjee J. Advances in the biology of astrocytomas[J]. Curr Opin Neurol, 2004, 17(6):655-662.
[11] 张珊文,肖绍文,刘长清,等.头颈鳞癌基因治疗结合放射治疗的临床研究[J].中华肿瘤杂志,2005,27(7):426-428.
[12] Tan PH, Chan CL, Chan C, et al. The evolving role of gene-based treatment in surgery[J]. Br J Surg, 2005, 92(12):1466-1480.
[13] Vlachaki MT, Chhikara M, Aguilar L, et al. Enhanced therapeutic effect of multiple injections of HSV-TK+GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model[J]. Int J Radiat Oncol Biol Phys, 2001, 51(4):1008-1017.
[14] Chhikara M, Huang H, Vlachaki MT, et al. Enhanced therapeutic effect of HSV-TK+GCV gene therapy and ionizing radiation for prostate cancer[J]. Mol Ther, 2001, 3(4):536-542.
[15] Rogulski KR, Wing MS, Paielli DL, et al. Double suicide gene therapy augments the antitumor activity of a replication-competent-lytic adenovirus through enhanced cytotoxicity and radiosensitization[J]. Hum Gene Ther, 2000, 11(1):67-76.
[16] 李勇,金宁,杨海山,等.内皮抑素基因联合放射治疗对大鼠Walker-256细胞种植性肿瘤的抑制作用[J].中华放射医学与防护杂志,2005,25(6):531-533.
[17] 隋刚,徐志飞,孙耀昌,等.内皮抑素基因治疗对小鼠肿瘤组织内新生血管形成抑制作用的实验研究[J].中华肿瘤防治杂志,2006,13(12):904-907.
[18] Ma B, Bristow RG, Kim J, et al. Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents[J]. J Clin Oncol, 2003, 21(14):2760-2776.
[19] Wu C, Li Xi, Tian M, et al. Effect of pEgr-TNF[alpha] gene radiotherapy on mice melanoma[J]. Cancer Res, 2005, 15(3):185-190.
[20] Quentin T, Henke C, Korabiowska M, et al. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression[J]. Anticancer Res, 2004, 24(2):1011-1023.
[21] Liu LL, Wang JH, Sun BS, et al. Combined IFN-gamma-endostatin gene-therapy and radio-therapy attanuates primary breast tumour growth and lung metastases in a murine model via enhanced CTL and NK cell activation and attenuated tumour angiogenesis:9565[J]. Br J Surg, 2006, 93(S3):11-12.
[22] 杨巍,吴丛梅,李修义,等.pEgr-IFNγ重组质粒辐射诱导表达及其抑瘤作用的实验研究[J].中华放射医学与防护杂志,2003,23(4):238-240.
[23] Greenberger JS, Bahri S, Jett J, et al. Consideration in optimizing radiation therapy for non-small cell lung cancer[J]. Chest, 1998, 113(1Suppl):46-52.
[24] Collis SJ, Ketner GW, Hicks JL, et al. Expression of the DNA-PK binding protein E4-34K fails to confer radiation sensitivity to mammalian cells[J]. Int J Radiat Biol, 2003, 79(1):53-60.